首页 | 本学科首页   官方微博 | 高级检索  
检索        

支气管动脉灌注联合125I粒子植入治疗中晚期肺癌的临床分析
引用本文:钟龙.支气管动脉灌注联合125I粒子植入治疗中晚期肺癌的临床分析[J].现代保健,2013(19):118-119.
作者姓名:钟龙
作者单位:湖南省常德市第二人民医院,湖南常德415000
摘    要:目的:分析中晚期肺癌患者采用支气管动脉灌注联合125I粒子植入治疗的临床疗效。方法:回顾本院收治的120例中晚期肺癌患者的临床资料,将其分为实验组(支气管动脉灌注、125I粒子植入联合)和对照组(支气管动脉灌注)两组,比较两组临床疗效。结果:实验组术后肿瘤大小、有效率优于对照组(P〈0.05)。结论:对于中晚期肺癌患者来说,实施支气管动脉灌注联合125I粒子植入治疗效果显著,成为首先治疗方案。

关 键 词:支气管动脉灌注  125I粒子植入  中晚期肺癌  肿瘤大小  生存时间

Clinical Analysis of Bronchial Artery Infusion Combined with 125I Seed Implantation in the Treatment of Advanced Lung Cancer
Authors:ZHONGLong
Institution:ZHONGLong.The Second People’s Hospital of Changde City,Changde 415000,China
Abstract:Objective:To analyze the clinical efficacy of bronchial artery infusion combined with 125I seed implantation in the treatment of advanced lung cancer.Method:Clinical data of 120 patients with advanced lung cancer in our hospital were analyzed,all patients were divided into experimental group( treated with bronchial artery infusion combined with 125I seed implantation)and control group( treated with bronchial artery infusion ),clinical effect of two groups were compared. Result:The postoperative tumor size,efficiency rate of experimental group were better than than control group,the difference was significant(P <0.05).Conclusion:For advanced lung cancer patients,the clinical efficacy of bronchial artery infusion combined with 125I seed implantation is significant,should be used as first treatment programs .
Keywords:Bronchial artery infusion  125I particle implantation  Advanced lung cancer  Tumor size  Survival time
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号